FDAFDA · Food and drugs·Recall number D-0862-2017
Infant 25% DEXTROSE Injection, USP, 2.5 g (250 mg/mL), 10 mL Unit of Use Single-dose Syringe per carton, Rx only, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1775-10
Published May 31, 2017 · Recall initiated: April 21, 2017
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter: human hair found within an internal sample syringe.
What to do
Voluntary: Firm initiated · Press Release
Recall details
- Brand
- DEXTROSE
- Manufacturer
- Hospira Inc.
- Distributor
- Nationwide in the USA and Puerto Rico
- Lot
- Lot 58382EV*, Exp 1OCT 2017, *lot may be followed by 01 or 02
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.